nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Estropipate—osteoporosis	0.0827	0.181	CbGbCtD
Alfuzosin—CYP3A4—Calcitriol—osteoporosis	0.0827	0.181	CbGbCtD
Alfuzosin—CYP3A4—Ergocalciferol—osteoporosis	0.0661	0.145	CbGbCtD
Alfuzosin—CYP3A4—Raloxifene—osteoporosis	0.0552	0.121	CbGbCtD
Alfuzosin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0533	0.117	CbGbCtD
Alfuzosin—CYP3A4—Cholecalciferol—osteoporosis	0.0426	0.0934	CbGbCtD
Alfuzosin—CYP3A4—Conjugated Estrogens—osteoporosis	0.0391	0.0858	CbGbCtD
Alfuzosin—CYP3A4—Estradiol—osteoporosis	0.0344	0.0753	CbGbCtD
Alfuzosin—Arthralgia—Pamidronate—osteoporosis	0.000677	0.00124	CcSEcCtD
Alfuzosin—Back pain—Conjugated Estrogens—osteoporosis	0.000676	0.00124	CcSEcCtD
Alfuzosin—Urticaria—Alendronate—osteoporosis	0.000676	0.00124	CcSEcCtD
Alfuzosin—Ill-defined disorder—Zoledronate—osteoporosis	0.000674	0.00124	CcSEcCtD
Alfuzosin—Abdominal pain—Alendronate—osteoporosis	0.000672	0.00124	CcSEcCtD
Alfuzosin—Sinusitis—Estradiol—osteoporosis	0.000672	0.00124	CcSEcCtD
Alfuzosin—Shock—Risedronate—osteoporosis	0.000671	0.00123	CcSEcCtD
Alfuzosin—Nervous system disorder—Risedronate—osteoporosis	0.000669	0.00123	CcSEcCtD
Alfuzosin—Discomfort—Pamidronate—osteoporosis	0.000669	0.00123	CcSEcCtD
Alfuzosin—Angioedema—Zoledronate—osteoporosis	0.000663	0.00122	CcSEcCtD
Alfuzosin—Skin disorder—Risedronate—osteoporosis	0.000663	0.00122	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000663	0.00122	CcSEcCtD
Alfuzosin—Abdominal pain—Raloxifene—osteoporosis	0.000661	0.00122	CcSEcCtD
Alfuzosin—Urticaria—Ibandronate—osteoporosis	0.000658	0.00121	CcSEcCtD
Alfuzosin—Malaise—Zoledronate—osteoporosis	0.000655	0.0012	CcSEcCtD
Alfuzosin—Abdominal pain—Ibandronate—osteoporosis	0.000655	0.0012	CcSEcCtD
Alfuzosin—Vertigo—Zoledronate—osteoporosis	0.000652	0.0012	CcSEcCtD
Alfuzosin—Syncope—Zoledronate—osteoporosis	0.000651	0.0012	CcSEcCtD
Alfuzosin—Oedema—Pamidronate—osteoporosis	0.000649	0.00119	CcSEcCtD
Alfuzosin—Infection—Pamidronate—osteoporosis	0.000644	0.00119	CcSEcCtD
Alfuzosin—Rhinitis—Estradiol—osteoporosis	0.000644	0.00119	CcSEcCtD
Alfuzosin—Urticaria—Calcitriol—osteoporosis	0.000644	0.00118	CcSEcCtD
Alfuzosin—Palpitations—Zoledronate—osteoporosis	0.000642	0.00118	CcSEcCtD
Alfuzosin—Abdominal pain—Calcitriol—osteoporosis	0.000641	0.00118	CcSEcCtD
Alfuzosin—Angioedema—Conjugated Estrogens—osteoporosis	0.000639	0.00117	CcSEcCtD
Alfuzosin—Shock—Pamidronate—osteoporosis	0.000638	0.00117	CcSEcCtD
Alfuzosin—Loss of consciousness—Zoledronate—osteoporosis	0.000638	0.00117	CcSEcCtD
Alfuzosin—Pharyngitis—Estradiol—osteoporosis	0.000638	0.00117	CcSEcCtD
Alfuzosin—Nervous system disorder—Pamidronate—osteoporosis	0.000636	0.00117	CcSEcCtD
Alfuzosin—Thrombocytopenia—Pamidronate—osteoporosis	0.000635	0.00117	CcSEcCtD
Alfuzosin—Urinary tract disorder—Estradiol—osteoporosis	0.000635	0.00117	CcSEcCtD
Alfuzosin—Vomiting—Etidronic acid—osteoporosis	0.000635	0.00117	CcSEcCtD
Alfuzosin—Tachycardia—Pamidronate—osteoporosis	0.000633	0.00116	CcSEcCtD
Alfuzosin—Connective tissue disorder—Estradiol—osteoporosis	0.000632	0.00116	CcSEcCtD
Alfuzosin—Urethral disorder—Estradiol—osteoporosis	0.00063	0.00116	CcSEcCtD
Alfuzosin—Rash—Etidronic acid—osteoporosis	0.000629	0.00116	CcSEcCtD
Alfuzosin—Dermatitis—Etidronic acid—osteoporosis	0.000629	0.00116	CcSEcCtD
Alfuzosin—Vertigo—Conjugated Estrogens—osteoporosis	0.000628	0.00116	CcSEcCtD
Alfuzosin—Hyperhidrosis—Pamidronate—osteoporosis	0.000627	0.00115	CcSEcCtD
Alfuzosin—Syncope—Conjugated Estrogens—osteoporosis	0.000627	0.00115	CcSEcCtD
Alfuzosin—Headache—Etidronic acid—osteoporosis	0.000625	0.00115	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000622	0.00114	CcSEcCtD
Alfuzosin—Asthenia—Estropipate—osteoporosis	0.00062	0.00114	CcSEcCtD
Alfuzosin—Chest pain—Zoledronate—osteoporosis	0.000618	0.00114	CcSEcCtD
Alfuzosin—Arthralgia—Zoledronate—osteoporosis	0.000618	0.00114	CcSEcCtD
Alfuzosin—Palpitations—Conjugated Estrogens—osteoporosis	0.000618	0.00114	CcSEcCtD
Alfuzosin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000614	0.00113	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000614	0.00113	CcSEcCtD
Alfuzosin—Pruritus—Estropipate—osteoporosis	0.000611	0.00112	CcSEcCtD
Alfuzosin—Discomfort—Zoledronate—osteoporosis	0.000611	0.00112	CcSEcCtD
Alfuzosin—Asthenia—Alendronate—osteoporosis	0.00061	0.00112	CcSEcCtD
Alfuzosin—Hypotension—Pamidronate—osteoporosis	0.000606	0.00111	CcSEcCtD
Alfuzosin—Dry mouth—Zoledronate—osteoporosis	0.000605	0.00111	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000604	0.00111	CcSEcCtD
Alfuzosin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000603	0.00111	CcSEcCtD
Alfuzosin—Pruritus—Alendronate—osteoporosis	0.000602	0.00111	CcSEcCtD
Alfuzosin—Dyspepsia—Risedronate—osteoporosis	0.000601	0.0011	CcSEcCtD
Alfuzosin—Eye disorder—Estradiol—osteoporosis	0.000601	0.0011	CcSEcCtD
Alfuzosin—Constipation—Ethinyl Estradiol—osteoporosis	0.000599	0.0011	CcSEcCtD
Alfuzosin—Flushing—Estradiol—osteoporosis	0.000597	0.0011	CcSEcCtD
Alfuzosin—Cardiac disorder—Estradiol—osteoporosis	0.000597	0.0011	CcSEcCtD
Alfuzosin—Chest pain—Conjugated Estrogens—osteoporosis	0.000595	0.00109	CcSEcCtD
Alfuzosin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000595	0.00109	CcSEcCtD
Alfuzosin—Asthenia—Ibandronate—osteoporosis	0.000594	0.00109	CcSEcCtD
Alfuzosin—Nausea—Etidronic acid—osteoporosis	0.000593	0.00109	CcSEcCtD
Alfuzosin—Oedema—Zoledronate—osteoporosis	0.000593	0.00109	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000591	0.00109	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000591	0.00109	CcSEcCtD
Alfuzosin—Diarrhoea—Estropipate—osteoporosis	0.000591	0.00109	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000589	0.00108	CcSEcCtD
Alfuzosin—Infection—Zoledronate—osteoporosis	0.000589	0.00108	CcSEcCtD
Alfuzosin—Fatigue—Risedronate—osteoporosis	0.000588	0.00108	CcSEcCtD
Alfuzosin—Pruritus—Ibandronate—osteoporosis	0.000586	0.00108	CcSEcCtD
Alfuzosin—Pain—Risedronate—osteoporosis	0.000584	0.00107	CcSEcCtD
Alfuzosin—Constipation—Risedronate—osteoporosis	0.000584	0.00107	CcSEcCtD
Alfuzosin—Angiopathy—Estradiol—osteoporosis	0.000583	0.00107	CcSEcCtD
Alfuzosin—Shock—Zoledronate—osteoporosis	0.000583	0.00107	CcSEcCtD
Alfuzosin—Diarrhoea—Alendronate—osteoporosis	0.000582	0.00107	CcSEcCtD
Alfuzosin—Asthenia—Calcitriol—osteoporosis	0.000582	0.00107	CcSEcCtD
Alfuzosin—Nervous system disorder—Zoledronate—osteoporosis	0.000581	0.00107	CcSEcCtD
Alfuzosin—Thrombocytopenia—Zoledronate—osteoporosis	0.00058	0.00107	CcSEcCtD
Alfuzosin—Mediastinal disorder—Estradiol—osteoporosis	0.000579	0.00107	CcSEcCtD
Alfuzosin—Tachycardia—Zoledronate—osteoporosis	0.000578	0.00106	CcSEcCtD
Alfuzosin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000577	0.00106	CcSEcCtD
Alfuzosin—Somnolence—Pamidronate—osteoporosis	0.000577	0.00106	CcSEcCtD
Alfuzosin—Skin disorder—Zoledronate—osteoporosis	0.000576	0.00106	CcSEcCtD
Alfuzosin—Pruritus—Calcitriol—osteoporosis	0.000574	0.00105	CcSEcCtD
Alfuzosin—Hyperhidrosis—Zoledronate—osteoporosis	0.000573	0.00105	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000572	0.00105	CcSEcCtD
Alfuzosin—Diarrhoea—Raloxifene—osteoporosis	0.000572	0.00105	CcSEcCtD
Alfuzosin—Dyspepsia—Pamidronate—osteoporosis	0.000571	0.00105	CcSEcCtD
Alfuzosin—Dizziness—Estropipate—osteoporosis	0.000571	0.00105	CcSEcCtD
Alfuzosin—Oedema—Conjugated Estrogens—osteoporosis	0.000571	0.00105	CcSEcCtD
Alfuzosin—Infection—Conjugated Estrogens—osteoporosis	0.000567	0.00104	CcSEcCtD
Alfuzosin—Diarrhoea—Ibandronate—osteoporosis	0.000567	0.00104	CcSEcCtD
Alfuzosin—Mental disorder—Estradiol—osteoporosis	0.000563	0.00104	CcSEcCtD
Alfuzosin—Dizziness—Alendronate—osteoporosis	0.000562	0.00103	CcSEcCtD
Alfuzosin—Shock—Conjugated Estrogens—osteoporosis	0.000561	0.00103	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00056	0.00103	CcSEcCtD
Alfuzosin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00056	0.00103	CcSEcCtD
Alfuzosin—Fatigue—Pamidronate—osteoporosis	0.000559	0.00103	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Risedronate—osteoporosis	0.000558	0.00103	CcSEcCtD
Alfuzosin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000557	0.00102	CcSEcCtD
Alfuzosin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000556	0.00102	CcSEcCtD
Alfuzosin—Constipation—Pamidronate—osteoporosis	0.000555	0.00102	CcSEcCtD
Alfuzosin—Pain—Pamidronate—osteoporosis	0.000555	0.00102	CcSEcCtD
Alfuzosin—Diarrhoea—Calcitriol—osteoporosis	0.000555	0.00102	CcSEcCtD
Alfuzosin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000554	0.00102	CcSEcCtD
Alfuzosin—Hypotension—Zoledronate—osteoporosis	0.000554	0.00102	CcSEcCtD
Alfuzosin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000553	0.00102	CcSEcCtD
Alfuzosin—Dizziness—Raloxifene—osteoporosis	0.000553	0.00102	CcSEcCtD
Alfuzosin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000552	0.00101	CcSEcCtD
Alfuzosin—Vomiting—Estropipate—osteoporosis	0.000549	0.00101	CcSEcCtD
Alfuzosin—Dizziness—Ibandronate—osteoporosis	0.000548	0.00101	CcSEcCtD
Alfuzosin—Rash—Estropipate—osteoporosis	0.000544	0.001	CcSEcCtD
Alfuzosin—Dermatitis—Estropipate—osteoporosis	0.000544	0.001	CcSEcCtD
Alfuzosin—Urticaria—Risedronate—osteoporosis	0.000542	0.000997	CcSEcCtD
Alfuzosin—Back pain—Estradiol—osteoporosis	0.000541	0.000995	CcSEcCtD
Alfuzosin—Headache—Estropipate—osteoporosis	0.000541	0.000995	CcSEcCtD
Alfuzosin—Vomiting—Alendronate—osteoporosis	0.000541	0.000994	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00054	0.000993	CcSEcCtD
Alfuzosin—Abdominal pain—Risedronate—osteoporosis	0.000539	0.000992	CcSEcCtD
Alfuzosin—Rash—Alendronate—osteoporosis	0.000536	0.000986	CcSEcCtD
Alfuzosin—Dermatitis—Alendronate—osteoporosis	0.000536	0.000985	CcSEcCtD
Alfuzosin—Feeling abnormal—Pamidronate—osteoporosis	0.000535	0.000983	CcSEcCtD
Alfuzosin—Hypotension—Conjugated Estrogens—osteoporosis	0.000533	0.000981	CcSEcCtD
Alfuzosin—Headache—Alendronate—osteoporosis	0.000533	0.00098	CcSEcCtD
Alfuzosin—Vomiting—Raloxifene—osteoporosis	0.000532	0.000978	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Pamidronate—osteoporosis	0.00053	0.000976	CcSEcCtD
Alfuzosin—Rash—Raloxifene—osteoporosis	0.000527	0.00097	CcSEcCtD
Alfuzosin—Dermatitis—Raloxifene—osteoporosis	0.000527	0.000969	CcSEcCtD
Alfuzosin—Somnolence—Zoledronate—osteoporosis	0.000527	0.000969	CcSEcCtD
Alfuzosin—Vomiting—Ibandronate—osteoporosis	0.000526	0.000968	CcSEcCtD
Alfuzosin—Headache—Raloxifene—osteoporosis	0.000524	0.000964	CcSEcCtD
Alfuzosin—Rash—Ibandronate—osteoporosis	0.000522	0.00096	CcSEcCtD
Alfuzosin—Dermatitis—Ibandronate—osteoporosis	0.000522	0.000959	CcSEcCtD
Alfuzosin—Dyspepsia—Zoledronate—osteoporosis	0.000522	0.000959	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00052	0.000956	CcSEcCtD
Alfuzosin—Ill-defined disorder—Estradiol—osteoporosis	0.000519	0.000955	CcSEcCtD
Alfuzosin—Headache—Ibandronate—osteoporosis	0.000519	0.000954	CcSEcCtD
Alfuzosin—Vomiting—Calcitriol—osteoporosis	0.000515	0.000948	CcSEcCtD
Alfuzosin—Nausea—Estropipate—osteoporosis	0.000513	0.000943	CcSEcCtD
Alfuzosin—Abdominal pain—Pamidronate—osteoporosis	0.000513	0.000943	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000512	0.000941	CcSEcCtD
Alfuzosin—Angioedema—Estradiol—osteoporosis	0.000511	0.00094	CcSEcCtD
Alfuzosin—Rash—Calcitriol—osteoporosis	0.000511	0.00094	CcSEcCtD
Alfuzosin—Fatigue—Zoledronate—osteoporosis	0.000511	0.00094	CcSEcCtD
Alfuzosin—Dermatitis—Calcitriol—osteoporosis	0.000511	0.000939	CcSEcCtD
Alfuzosin—Headache—Calcitriol—osteoporosis	0.000508	0.000934	CcSEcCtD
Alfuzosin—Somnolence—Conjugated Estrogens—osteoporosis	0.000507	0.000933	CcSEcCtD
Alfuzosin—Constipation—Zoledronate—osteoporosis	0.000507	0.000932	CcSEcCtD
Alfuzosin—Pain—Zoledronate—osteoporosis	0.000507	0.000932	CcSEcCtD
Alfuzosin—Nausea—Alendronate—osteoporosis	0.000505	0.000929	CcSEcCtD
Alfuzosin—Malaise—Estradiol—osteoporosis	0.000505	0.000928	CcSEcCtD
Alfuzosin—Vertigo—Estradiol—osteoporosis	0.000503	0.000924	CcSEcCtD
Alfuzosin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000502	0.000924	CcSEcCtD
Alfuzosin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000502	0.000924	CcSEcCtD
Alfuzosin—Syncope—Estradiol—osteoporosis	0.000502	0.000923	CcSEcCtD
Alfuzosin—Nausea—Raloxifene—osteoporosis	0.000497	0.000914	CcSEcCtD
Alfuzosin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000495	0.000911	CcSEcCtD
Alfuzosin—Palpitations—Estradiol—osteoporosis	0.000494	0.000909	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000493	0.000906	CcSEcCtD
Alfuzosin—Fatigue—Conjugated Estrogens—osteoporosis	0.000492	0.000905	CcSEcCtD
Alfuzosin—Nausea—Ibandronate—osteoporosis	0.000492	0.000905	CcSEcCtD
Alfuzosin—Loss of consciousness—Estradiol—osteoporosis	0.000492	0.000904	CcSEcCtD
Alfuzosin—Asthenia—Risedronate—osteoporosis	0.00049	0.0009	CcSEcCtD
Alfuzosin—Feeling abnormal—Zoledronate—osteoporosis	0.000488	0.000898	CcSEcCtD
Alfuzosin—Pain—Conjugated Estrogens—osteoporosis	0.000488	0.000897	CcSEcCtD
Alfuzosin—Constipation—Conjugated Estrogens—osteoporosis	0.000488	0.000897	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000485	0.000891	CcSEcCtD
Alfuzosin—Pruritus—Risedronate—osteoporosis	0.000483	0.000888	CcSEcCtD
Alfuzosin—Nausea—Calcitriol—osteoporosis	0.000481	0.000885	CcSEcCtD
Alfuzosin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000479	0.000881	CcSEcCtD
Alfuzosin—Arthralgia—Estradiol—osteoporosis	0.000476	0.000876	CcSEcCtD
Alfuzosin—Chest pain—Estradiol—osteoporosis	0.000476	0.000876	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000473	0.00087	CcSEcCtD
Alfuzosin—Urticaria—Zoledronate—osteoporosis	0.000471	0.000866	CcSEcCtD
Alfuzosin—Discomfort—Estradiol—osteoporosis	0.000471	0.000866	CcSEcCtD
Alfuzosin—Abdominal pain—Zoledronate—osteoporosis	0.000468	0.000861	CcSEcCtD
Alfuzosin—Diarrhoea—Risedronate—osteoporosis	0.000467	0.000859	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000467	0.000858	CcSEcCtD
Alfuzosin—Dry mouth—Estradiol—osteoporosis	0.000466	0.000857	CcSEcCtD
Alfuzosin—Asthenia—Pamidronate—osteoporosis	0.000465	0.000856	CcSEcCtD
Alfuzosin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000463	0.000851	CcSEcCtD
Alfuzosin—Pruritus—Pamidronate—osteoporosis	0.000459	0.000844	CcSEcCtD
Alfuzosin—Oedema—Estradiol—osteoporosis	0.000457	0.00084	CcSEcCtD
Alfuzosin—Infection—Estradiol—osteoporosis	0.000454	0.000834	CcSEcCtD
Alfuzosin—Urticaria—Conjugated Estrogens—osteoporosis	0.000453	0.000834	CcSEcCtD
Alfuzosin—Dizziness—Risedronate—osteoporosis	0.000451	0.00083	CcSEcCtD
Alfuzosin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000451	0.00083	CcSEcCtD
Alfuzosin—Shock—Estradiol—osteoporosis	0.000449	0.000826	CcSEcCtD
Alfuzosin—Nervous system disorder—Estradiol—osteoporosis	0.000448	0.000824	CcSEcCtD
Alfuzosin—Tachycardia—Estradiol—osteoporosis	0.000446	0.00082	CcSEcCtD
Alfuzosin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000445	0.000818	CcSEcCtD
Alfuzosin—Diarrhoea—Pamidronate—osteoporosis	0.000444	0.000816	CcSEcCtD
Alfuzosin—Skin disorder—Estradiol—osteoporosis	0.000444	0.000816	CcSEcCtD
Alfuzosin—Hyperhidrosis—Estradiol—osteoporosis	0.000441	0.000812	CcSEcCtD
Alfuzosin—Rash—Ethinyl Estradiol—osteoporosis	0.000441	0.000812	CcSEcCtD
Alfuzosin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000441	0.000811	CcSEcCtD
Alfuzosin—Headache—Ethinyl Estradiol—osteoporosis	0.000438	0.000806	CcSEcCtD
Alfuzosin—Vomiting—Risedronate—osteoporosis	0.000434	0.000798	CcSEcCtD
Alfuzosin—Rash—Risedronate—osteoporosis	0.00043	0.000791	CcSEcCtD
Alfuzosin—Dermatitis—Risedronate—osteoporosis	0.00043	0.000791	CcSEcCtD
Alfuzosin—Dizziness—Pamidronate—osteoporosis	0.000429	0.000789	CcSEcCtD
Alfuzosin—Headache—Risedronate—osteoporosis	0.000428	0.000786	CcSEcCtD
Alfuzosin—Asthenia—Zoledronate—osteoporosis	0.000425	0.000782	CcSEcCtD
Alfuzosin—Pruritus—Zoledronate—osteoporosis	0.000419	0.000771	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000416	0.000765	CcSEcCtD
Alfuzosin—Nausea—Ethinyl Estradiol—osteoporosis	0.000416	0.000765	CcSEcCtD
Alfuzosin—Vomiting—Pamidronate—osteoporosis	0.000412	0.000759	CcSEcCtD
Alfuzosin—Asthenia—Conjugated Estrogens—osteoporosis	0.000409	0.000753	CcSEcCtD
Alfuzosin—Rash—Pamidronate—osteoporosis	0.000409	0.000752	CcSEcCtD
Alfuzosin—Dermatitis—Pamidronate—osteoporosis	0.000409	0.000752	CcSEcCtD
Alfuzosin—Headache—Pamidronate—osteoporosis	0.000406	0.000747	CcSEcCtD
Alfuzosin—Somnolence—Estradiol—osteoporosis	0.000406	0.000747	CcSEcCtD
Alfuzosin—Diarrhoea—Zoledronate—osteoporosis	0.000405	0.000746	CcSEcCtD
Alfuzosin—Nausea—Risedronate—osteoporosis	0.000405	0.000745	CcSEcCtD
Alfuzosin—Pruritus—Conjugated Estrogens—osteoporosis	0.000404	0.000742	CcSEcCtD
Alfuzosin—Dyspepsia—Estradiol—osteoporosis	0.000402	0.000739	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000394	0.000725	CcSEcCtD
Alfuzosin—Fatigue—Estradiol—osteoporosis	0.000394	0.000724	CcSEcCtD
Alfuzosin—Dizziness—Zoledronate—osteoporosis	0.000392	0.000721	CcSEcCtD
Alfuzosin—Constipation—Estradiol—osteoporosis	0.000391	0.000718	CcSEcCtD
Alfuzosin—Pain—Estradiol—osteoporosis	0.000391	0.000718	CcSEcCtD
Alfuzosin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00039	0.000718	CcSEcCtD
Alfuzosin—Nausea—Pamidronate—osteoporosis	0.000385	0.000709	CcSEcCtD
Alfuzosin—Dizziness—Conjugated Estrogens—osteoporosis	0.000377	0.000694	CcSEcCtD
Alfuzosin—Vomiting—Zoledronate—osteoporosis	0.000377	0.000693	CcSEcCtD
Alfuzosin—Feeling abnormal—Estradiol—osteoporosis	0.000376	0.000692	CcSEcCtD
Alfuzosin—Rash—Zoledronate—osteoporosis	0.000374	0.000687	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Estradiol—osteoporosis	0.000373	0.000687	CcSEcCtD
Alfuzosin—Dermatitis—Zoledronate—osteoporosis	0.000373	0.000686	CcSEcCtD
Alfuzosin—Headache—Zoledronate—osteoporosis	0.000371	0.000683	CcSEcCtD
Alfuzosin—Vomiting—Conjugated Estrogens—osteoporosis	0.000363	0.000667	CcSEcCtD
Alfuzosin—Urticaria—Estradiol—osteoporosis	0.000363	0.000667	CcSEcCtD
Alfuzosin—Abdominal pain—Estradiol—osteoporosis	0.000361	0.000664	CcSEcCtD
Alfuzosin—Rash—Conjugated Estrogens—osteoporosis	0.00036	0.000662	CcSEcCtD
Alfuzosin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000359	0.000661	CcSEcCtD
Alfuzosin—Headache—Conjugated Estrogens—osteoporosis	0.000357	0.000657	CcSEcCtD
Alfuzosin—Nausea—Zoledronate—osteoporosis	0.000352	0.000647	CcSEcCtD
Alfuzosin—Nausea—Conjugated Estrogens—osteoporosis	0.000339	0.000623	CcSEcCtD
Alfuzosin—Asthenia—Estradiol—osteoporosis	0.000328	0.000603	CcSEcCtD
Alfuzosin—Pruritus—Estradiol—osteoporosis	0.000323	0.000594	CcSEcCtD
Alfuzosin—Diarrhoea—Estradiol—osteoporosis	0.000312	0.000575	CcSEcCtD
Alfuzosin—Dizziness—Estradiol—osteoporosis	0.000302	0.000555	CcSEcCtD
Alfuzosin—Vomiting—Estradiol—osteoporosis	0.00029	0.000534	CcSEcCtD
Alfuzosin—Rash—Estradiol—osteoporosis	0.000288	0.00053	CcSEcCtD
Alfuzosin—Dermatitis—Estradiol—osteoporosis	0.000288	0.000529	CcSEcCtD
Alfuzosin—Headache—Estradiol—osteoporosis	0.000286	0.000526	CcSEcCtD
Alfuzosin—Nausea—Estradiol—osteoporosis	0.000271	0.000499	CcSEcCtD
